ACSL4 and head and neck squamous cell carcinoma: Therefore, ACSL4, SLC7A11, and GPX4 are key links necessary links in the synergistic effect between these two, providing an experimental basis for HNSCC treatment with ferroptosis inducers and PLK1 inhibitors.